secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sigyn Therapeutics, Inc. (SIGY)
CIK:        0001642159
Form:       8-K/A
Filed at:   2024-10-16T23:59:59+00:00
Accession:  0001493152-24-041285
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Sigyn corrects prior error; debenture conversion adds 118,700 shares, 9.1% share increase
--------------------------------------------------------------------------------

- Corrected prior error: sellers were not controlled by an executive officer.
- $474,793 of convertible debentures converted at $4.00/share for 118,700 shares.
- Shares issued with Rule 144 legend, exempt under Section 4(a)(2).
- Outstanding common shares increased from 1,301,978 to 1,420,678.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642159/000149315224041285/0001493152-24-041285-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642159/000149315224041285/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-041285

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer